Pharmapack 2021: Convergence of trends are pushing drug delivery devices towards connectivity, says Nemera
Electronic devices and connectivity are being progressively included in drug delivery devices, bringing positive outcomes to all stakeholders, according to drug device combinations specialist, Nemera Tuesday
Introducing the day’s online conference track, Digital Health, Connectivity and Patient Centricity at Pharmapack Europe 2021, Séverine Duband, Marketing Director at Nemera said there was currently a convergence of major trends towards digital health and connected devices.
She said the rise of biologics, especially to treat chronic diseases, had increased the need for advanced, complex delivery systems such as electronic devices with automatic injection.
“Another important, growing trend is self-administration and homecare, all the more fuelled since the COVID-19 epidemic with people trying to avoid having to spend time in the clinic or hospital care setting,” she told delegates. “This also raised the need for more interactive and automated devices that can rerun the administration process for the patient in a serious way.”
Ms Duband also highlighted the increasing focus on patients and the challenge of ensuring they can increase adherence to treatment.
“Making devices that are more user-friendly, seamless and using those latest innovations within the connected field really help to bring added value into the regimen treatments, adherence and monitoring,” she said.
The final major trend towards a new digital age was the rising adoption of connected health within the global population, who were already using smartphones to track their health and fitness, according to Ms Duband.
“That can go up to disease management tracking with new applications and even up to a certain extent, to closed loop systems; very advanced technologies which manage not only the treatment but also the diagnoses, and can adjust the dose needed by the patient,” she said. “So in a nutshell, all these trends fuel into drug delivery devices and have also set the ground for the growing share of which they are taking within the connected space.”
Pharmapack Europe 2021: Hybrid Event
@PharmapackEU
Online Conference: 27 Sept. - 22 Oct. 2021
In-person Event: 13 & 14 Oct. 2021, Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance